A naturally unbalanced combat

Nature Medicine

Volumn 3, Issue 2, 1997, Pages 156-157

  Zagury, D ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; PRIORITY JOURNAL; VIRUS MUTATION;

HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0031042037     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0297-156     Document Type: Note

References (13)

1. Borrow, P. et al. Antiviral pressure exerted by human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3, 205-211 (1997).
2. Goulder, P.J.R. et al. Late escape from an immunodominant cytotoxic T lymphocyte response associated with progression to AIDS. Nature Med. 3, 212-217 (1997).
3. Zinkernagel, R.M. & Doherty, P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702 (1974).
4. Zagury, J.F. et al. Model of AIDS immunopathogenesis based on the HIV-1 gp120 and Tat-induced dysregulation of uninfected immune cells. Cell. Pharm. AIDS Sci. 3, 123-128 (1996).
5. Li, C.J. et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268, 429-431 (1995).
6. Nixon D.F. & McMichael, A.J. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 5, 1049-1059 (1991).
7. Schupbach, J. et al. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science 224, 503-505 (1984).
8. Zagury, D. et al. A group specific anamnestic immune reaction against HIV-1-induced by a candidate vaccine against AIDS. Nature 332, 728-731 (1988).
9. Picard, O. et al. A two year follow up of anti-HIV-1 immune reaction in HIV-1 gp160 immunized healthy seronegative humans: Evidence for persistent cell-mediated immunity. J. AIDS 5, 539-546 (1992).
10. + cytolytic T lymphocytes isolated from seronegative humans immunized by candidate HIV-1 vaccines. J. Exp. Med. 176, 1531-1537 (1992).
11. Achour, A. et al. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc. Natl. Acad. Sci. USA 87, 7045-7049 (1990).
12. Achour, A. et al. Induction of anti-gp160 cytotoxic T cells cross-reacting with various V3 loop P18 peptides in human immunodeficiency virus type 1 envelope-immunized individuals. J. Virol. 70, 6741-6750 (1996).
13. Zagury, D. et al. Long-term cultures of HTLV-III-infected T cells: A model of cytopathology of T-cell depletion in AIDS. Science 231, 850-853 (1986).